Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating study
暂无分享,去创建一个
M. Gobbi | G. Gaidano | A. Pancrazzi | A. Vannucchi | F. Pane | G. Specchia | A. Iurlo | H. Achenbach | V. Stefano | F. Palandri | Jonathan Smith | N. Cascavilla | M. Liberati | P. Wilde | M. D’adda | Rajmonda Fjerza